---
title: "MedPlus Subsidiary Faces Three-Day Drug License Suspensions at Three Karnataka Stores"
type: "News"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/270737408.md"
description: "MedPlus Health Services Ltd. announced that its subsidiary, Optival Health Solutions Private Limited, received three-day drug license suspensions for three stores in Karnataka due to alleged violations of the Drugs and Cosmetics Act, 1940. The suspensions are expected to result in a potential revenue loss of Rs 3.24 lakh. The company emphasized the limited financial impact but noted ongoing regulatory scrutiny."
datetime: "2025-12-24T14:54:59.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/270737408.md)
  - [en](https://longbridge.com/en/news/270737408.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/270737408.md)
---

> 支持的語言: [简体中文](https://longbridge.com/zh-CN/news/270737408.md) | [English](https://longbridge.com/en/news/270737408.md)


# MedPlus Subsidiary Faces Three-Day Drug License Suspensions at Three Karnataka Stores

### Claim 70% Off TipRanks This Holiday Season

-   Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
-   Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential

MedPlus Health Services Ltd. ( (IN:MEDPLUS) ) has shared an announcement.

MedPlus Health Services Ltd. has disclosed that its subsidiary Optival Health Solutions Private Limited has received three suspension orders for drug licenses covering three stores in Karnataka, located at Jayanagar 9th Block, T R Nagar, and Shiggon Haveri. The suspensions, issued by Assistant Directors of the Drugs Control Administration in Bangalore Circle-3 and Haveri Circle under Rule 65 of the Drugs and Cosmetics Act, 1940 and corresponding Rules, each apply for a three-day period and are linked to alleged violations of those provisions. The company estimates a combined potential revenue loss of roughly Rs 3.24 lakh from the temporary shutdowns, indicating a limited financial impact relative to overall operations, but highlighting ongoing regulatory scrutiny over compliance in its retail pharmacy network.

**More about MedPlus Health Services Ltd.**

MedPlus Health Services Ltd. operates in the Indian retail pharmacy and healthcare services industry, primarily through its chain of MedPlus pharmacies and subsidiary Optival Health Solutions Private Limited. The company focuses on providing prescription drugs, over-the-counter medicines and related healthcare products across multiple states, positioning itself as a major organized pharmacy player in urban and semi-urban markets.

**Average Trading Volume:** 21,726

**Technical Sentiment Signal:** Buy

**Current Market Cap:** 98.84B INR

See more insights into MEDPLUS stock on TipRanks’ Stock Analysis page.

## 相關資訊與研究

- [Rossari Subsidiary Unitop Chemicals to Sell Non-Core Mumbai Office for Rs 10 Crore](https://longbridge.com/zh-HK/news/281655433.md)
- [Trump signs order imposing 100 percent tariff on brand name drugs](https://longbridge.com/zh-HK/news/281579227.md)
- [UK reaches agreement with US for British drugs to be tariff free](https://longbridge.com/zh-HK/news/281563745.md)
- [Prestige Estates secures land parcel in Gurugram with 42 billion rupees GDV potential](https://longbridge.com/zh-HK/news/281380661.md)
- [HFCL Extends Rs 30 Crore Corporate Guarantee for Subsidiary HTL](https://longbridge.com/zh-HK/news/280883495.md)